Scandinavian ChemoTech
3.85 SEK
+1.58 %
Less than 1K followers
CMOTEC B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Scandinavian ChemoTech
EV/S
Median 2019-2022
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 10.03 | 13.02 | 16.37 | 4.85 | 2.59 | 1.79 | 5.02 |
| Shares | 4.5 | 6.3 | 9.0 | 12.5 | 18.7 | 23.3 | 25.5 |
| Market cap | 44.9 | 81.9 | 147.5 | 60.7 | 48.4 | 41.8 | 127.8 |
| Enterprise value | 47.4 | 80.5 | 138.9 | 54.8 | - | - | - |
| EV/S | 85.2 | 614.3 | 2,833.7 | 116.6 | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | - | - | - |
| EV/EBIT | neg. | neg. | neg. | neg. | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 4.62 | 8.87 | 6.17 | 4.34 | 4.39 | 6.99 | 40.11 |
| P/S | 80.8 | 625.3 | 3,009.8 | 129.1 | 17.2 | 6.4 | 10.4 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 55.6 % | 57.8 % | 92.7 % | 64.5 % | 74.2 % | 44.7 % | 24.1 % |
| Gearing ratio | 54.4 % | 0.6 % | 0.2 % | - | - | - | 206.1 % |